Navigation Links
Nuvu Cameras to commercialize world's most sensitive camera
Date:4/28/2010

This release is available in French.

Montreal, April 28, 2010 Olivier Daigle, recipient of the People's Choice Award for discovery of the year given by Qubec Science magazine, has launched a new company with his partner, Marie-Eve Ducharme. Nv Camēras will commercialize their EMCCD camera, which is considered to be the most sensitive in the world.

Olivier Daigle designed the camera as part of his PhD studies in astrophysics at the Universit de Montral Department of Physics. The camera was conceived under the direction of Claude Carignan and Photon etc inc., a research and development company that specializes in photonic measurement and analysis instruments. Nv Camēras' launch comes after four years of research and development in uncharted territory. Thanks to substantial noise reduction, the camera can quadruple the effectiveness of current telescopes in applications requiring either short exposure or low levels of light.

NASA purchases copy of camera's controller

The camera was initially designed as part of the international 3D-NTT instrument project. Its installation is planned for early 2011 in Chili at the New Technology Telescope, which belongs to the European Southern Observatory. In May 2009, NASA purchased a copy of the camera's controller (i.e. its brain). Shortly after, the University of So Paulo bought two copies of the controller for an astronomical instrument to be set up at the Chili's Southern Astrophysical Research Telescope in July 2010.

Nv Camēras' will prioritize domains that abandoned EMCCD technology because of poor performance of cameras currently on the market. The exceptional performance of the Nv EMCCD technology now makes it possible to undertake high-contrast spectroscopy and extremely low-flux imagery. Other promising examples of Nv fields of application: biomedical diagno
'/>"/>

Contact: Olivier Daigle
odaigle@nuvucameras.com
514-699-9117
University of Montreal
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America
2. Gunther von Hagens BODY WORLDS of Animals Opening March 19 at the Neunkirchen Zoo
3. Life Ionizers Drums to a New Beat with Julian Pavone, the Worlds Youngest Drummer and Inventor
4. SpiderTech Announces Kinesiology Tape Breakthrough, SpiderTech Gentle – Kinesiology Tape for Even the Most Sensitive Skin
5. Ultrasensitive detector pinpoints big problem in tiny fetal heart
6. Impulsive-antisocial personality traits linked to a hypersensitive brain reward system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... (PRWEB) , ... August 30, 2015 , ... ... Ultrasound (HIFU) medical devices for the treatment of prostate cancer, has announced the ... this summer at the treatment center in Puerto Vallarta, Mexico. , The Sonablate® ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... inventors from Miller Place, N.Y. "I specialize in manual therapy, and my invention ... it can be used for additional muscle dysfunction throughout the body." , They ...
(Date:8/29/2015)... NY (PRWEB) , ... August 29, 2015 , ... Next ... end of summer (which astronomically, officially ends on September 22nd this year). For IT ... cyber security hangovers linger on which could prove far more costly than a simple ...
(Date:8/29/2015)... ... 2015 , ... Vascular Health Sciences announced today that an ... HP, and that all claims and counterclaims have been irrevocably dismissed. , In ... the United States District Court for the Southern District of Texas for breach ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department of Workforce Investment ... position they are applying for, they are unable to pass the initial drug test ... drug testing policies in order to be able to hire long-term, skilled talent. (1) ...
Breaking Medicine News(10 mins):Health News:Image Fusion Technology Combines MRI and Ultrasound Images to Treat Prostate Cancer 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4
... MADISON - For the millions of Americans whose vision is ... lowly neural progenitor// cell may be riding to the rescue. ... derived from human fetal stem cells have been shown to ... to the kinds of diseases that afflict humans. The new ...
... Diabetes and high blood pressure, two conditions rooted in ... than race alone in determining// who is mostly likely ... from cardiologists at Johns Hopkins. Each year, nearly 300,000 ... ,Experts say that racial disparities have long been known ...
... lawmakers Monday it could be a decade or more before ... drugs // in the way the agency approves knockoffs of ... Janet Woodcock's testimony could benefit companies such as Amgen Inc. ... the U.S. for their products, some of the most complex ...
... blood thinner, one of the first signs the drug is ... and bruising,// an inconvenient side effect of preventing the blood ... stroke. While potentially life-saving, the drugs can also pose a ... of blood levels. ,So when he didn’t see ...
... disease causing tennis-ball-size ulcers so painful that victims feel ... than two years// become the second illness after smallpox ... and other preventive methods, the United Nations health agency ... of years of effort by local and international groups ...
... secretary said that computer based therapy will be available ... will be available to all patients in England from ... Beating the blues have been designed as therapies for ... warned that computer aided programs may not be suitable ...
Cached Medicine News:Health News:Stem Cell Therapy Shows Promise for Rescuing Deteriorating Vision 2Health News:Stem Cell Therapy Shows Promise for Rescuing Deteriorating Vision 3Health News:Who Gets Heart Failure? Race Takes Back Seat to Diabetes and High Blood Pressure 2Health News:Who Gets Heart Failure? Race Takes Back Seat to Diabetes and High Blood Pressure 3Health News:FDA Cites Challenges of Generic Biotech 2Health News:New Blood Thinner May Work Without Bleeding Risk 2Health News:Ancient Worm Disease Could Be Eradicated Within Two Years, UN Agency Reports 2Health News:Computer Based Therapy For Depression 2
(Date:8/27/2015)... FRANKLIN, Mass. , Aug. 27, 2015 /PRNewswire/ ... in the KSSTA Knee Journal, compared the Arthrosurface ... "inlay" Arthroplasty design, versus an "onlay" design implant ... showed similar improvements in function and pain scores, ... showed progression of osteoarthritis (OA). However, 53% of ...
(Date:8/27/2015)... Aug. 27, 2015 Biosimilars are not ... the U.S. Food and Drug Administration (FDA) for ... in its draft guidance issued today. The FDA,s ... proposes distinguishable names, calling for biological products to ... suffix. This proposal reflects the agency,s thinking that ...
(Date:8/27/2015)... , August 27, 2015 According to ... (Transfer, Hammock, Toilet, Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, ... Forecast to 2020", published by MarketsandMarkets, the Medical Lifting Sling Market ... 411.5 Million in 2015, at a CAGR of 11.4 % from ... ma rket data T ables and ...
Breaking Medicine Technology:Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
... Failed to Reach Statistical ... ... /PRNewswire-,FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR ) and its,wholly- ... pivotal trials of OvaRex(R) MAb for the,treatment of advanced ovarian cancer. ...
... Cancer Patients, ROCKVILLE, Md., Dec. 4 ... company developing,therapeutics for the treatment of cancer and ... multi-center Phase 2 clinical trial with,MKC-1 in patients ... study will be to determine the antitumor activity ...
Cached Medicine Technology:Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 2Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 3Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 4EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 2EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 3EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 4
... VasoSeal VHD was the ... stop bleeding after diagnostic ... radiology procedures. It is ... device approved for immediate ...
... Hemostats First Stop absorbable collagen hemostat. FirstStop ... superior handling and removal characteristics. It can ... to fit the wound. FirstStop products are ... be peeled away after hemostasis is achieved. ...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
Medicine Products: